Search

everythinglearnresearchcommunity

for

Search:↓

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Some children with localized scleroderma are rarely resistant to methotrexate, and no common profile for resistance was found.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Low-level laser therapy did not reduce licking or improve lesions in dogs with ALD but did increase hair growth.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Eight people with severe hair loss grew their hair back naturally.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.